FindTrial
Sign In

TO STUDY EFFECT OF ABHAYADI GHANAWATI COMPARED TO TABLET RANITIDINE IN MANAGEMENT OF URDHVAG AMLAPITTA

A COMPARATIVE CLINICAL STUDY OF ABHAYADI GHANAWATI AND TABLET RANITIDINE IN MANAGEMENT OF URDHVAG AMLAPITTA - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/086844
Enrollment
35
Registered
2025-05-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K290- Acute gastritis

Interventions

Intervention1: NA: NA Control Intervention1: NA: NA

Sponsors

SELF
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients having signs and symptoms of urdhvag amlapitta as described in ayurvedic samhitas that is chardi,amlodgar,hrullas,hruda kantadaha,udarda,shirashool,hastapada daha,aruchi,maddalotpatti

Exclusion criteria

Exclusion criteria: patients suffering gastric ulcers, duodenal ulcers pregnant and lactating women CA stomach,oesophagus,esophageal varices, hematemesis patients having hepatic and renal disorders immunocompromised patients,blood coagulation systemic diseases like HTN,TB,DM

Design outcomes

Primary

MeasureTime frame
4 weeksTimepoint: ABHAYADI GHANAWATI IS EFFECTIVE IN URDHVAG AMLAPITTA—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactPRANALI UGHADE

COLLEGE OF AYURVEDA AND RESEARCH CENTRE NIGDI PUNE

khobragaderupali19@gmail.com8378929859

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026